← Leaderboards
Indra Adrianto
Henry Ford Health System
$1,711,081
Attributed
$3,533,370
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,533,370 · 5
By mechanism
R01$1,553,425 · 1
R61$746,480 · 1
R21$519,840 · 1
R33$380,000 · 1
UG3$333,625 · 1
Top collaborators
- Qing-Sheng Mi10 shared
- Li Zhou1 shared
Most similar at Henry Ford Health System
Same institution · by research overlap
- Qing-Sheng Mi$11,290,442
- Keoki Williams$18,740,627
- Benjamin A. Rybicki$11,679,004
- Ganesa Rebecca Wegienka$6,668,221
Others in their field
Other Emerging Leaders on “Inflammatory”
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$21,969,486
- Gary Fanger · Rise Therapeutics, Llc$20,823,569
- Gina Montealegre · Leidos Biomedical Research, Inc.$19,781,641
- Jeffrey Reich · Sparian Biosciences, Inc.$13,729,307
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
Research focus
InflammatoryInsightSkinImmunologistSkin DisorderVariantProceduresHidradenitis SuppurativaImmuneAutoimmune DiseasesAfrican American PopulationPainCohortResearch PersonnelCellsAbscessInflammationMonocyteChronicAreaSingle-Cell Rna SequencingEthnic OriginGenome Wide Association StudyAdmixture Mapping
Grant awards (10)
Whole genome sequencing analysis of hidradenitis suppurativa$614,933
R01 · FY2025 · AR
Anti-CD38 isatuximab Immunotherapy in Hidradenitis Suppurativa: a randomized, double-blinded, placebo-controlled, seamless phase 2a/2b trial$333,625
UG3 · FY2025 · AR
Identification of Specific Immune Responses in African American Female Patients with Hidradenitis Suppurativa$219,799
R01 · FY2025 · AR
Whole genome sequencing analysis of hidradenitis suppurativa$718,693
R01 · FY2024 · AR
Genetic risk of hidradenitis suppurativa in African Americans$167,200
R21 · FY2023 · AR
Genetic risk of hidradenitis suppurativa in African Americans$200,640
R21 · FY2022 · AR
Genetic risk of hidradenitis suppurativa in African Americans$152,000
R21 · FY2022 · AR
Uncover the new subsets of epidermal Langerhans cells$380,000
R33 · FY2021 · AR
Uncover the new subsets of epidermal Langerhans cells$370,230
R61 · FY2020 · AR
Uncover the new subsets of epidermal Langerhans cells$376,250
R61 · FY2019 · AR